MedPath

Hydroxide ion

Generic Name
Hydroxide ion
Drug Type
Small Molecule
Chemical Formula
HO
CAS Number
14280-30-9
Unique Ingredient Identifier
9159UV381P

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Research Report

Published: Oct 29, 2025

The Hydroxide Ion (DB14522): A Comprehensive Analysis of its Physicochemical Properties, Physiological Significance, and Pharmacological Applications

Executive Summary

The hydroxide ion ($OH^{-}$), cataloged in the DrugBank database under the accession number DB14522, represents a unique case study in pharmacological classification. It is not a therapeutic agent in its own right but rather a fundamental diatomic anion indispensable to the fields of chemistry, biology, and medicine. This report provides an exhaustive analysis of the hydroxide ion, clarifying its identity and deconstructing its multifaceted roles. Its pharmacological relevance is not derived from its use as a standalone drug, but from its function as a reactive chemical moiety within a range of established pharmaceutical compounds, most notably the metal hydroxides employed as antacids. Furthermore, it serves as a critical excipient in drug formulation and manufacturing, primarily for pH adjustment and, in the case of aluminum hydroxide, as a vaccine adjuvant.

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/04/02
Phase 2
Active, not recruiting
2023/06/08
Phase 1
Completed
Combined Military Hospital Abbottabad
2019/11/26
Phase 1
Completed
2019/06/20
Phase 3
Completed
2018/11/20
Phase 4
UNKNOWN
2017/11/01
Phase 2
Completed
National University Health System, Singapore
2017/07/06
Early Phase 1
UNKNOWN
2011/05/05
Phase 2
Completed
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
2010/07/23
Phase 2
UNKNOWN
Instituto do Cancer do Estado de São Paulo
2007/09/14
Phase 2
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.